Cascaded Multimodal Deep Learning in the Differential Diagnosis, Progression Prediction, and Staging of Alzheimer's and Frontotemporal Dementia

Gianmarco Guarnier,Janis Reinelt,Eóin N. Molloy,Paul Glad Mihai,Pegah Einaliyan,Sofie Valk,Augusta Modestino,Matteo Ugolini,Karsten Mueller,Qiong Wu,Anahit Babayan,Marco Castellaro,Arno Villringer,Nico Scherf,Konstantin Thierbach,Matthias L Schroeter,Alzheimers Disease Neuroimaging Initiative,Australian Imaging Biomarkers and Lifestyle flagship study of ageing,Frontotemporal Lobar Degeneration Neuroimaging Initiative
DOI: https://doi.org/10.1101/2024.09.23.24314186
2024-10-17
Abstract:Dementia syndromes are complex sequelae whose multifaceted nature poses significant challenges in the diagnosis, prognosis, and treatment of patients. Despite the availability of large open-source data fueling a wealth of promising research, effective translation of preclinical findings to clinical practice remains difficult. This barrier is largely due to the complexity of unstructured and disparate preclinical and clinical data, which traditional analytical methods struggle to handle. Novel analytical techniques involving Deep Learning (DL), however, are gaining significant traction in this regard. Here, we have investigated the potential of a cascaded multimodal DL-based system (TelDem), assessing the ability to integrate and analyze a large, heterogeneous dataset (n=7159 patients), applied to three clinically relevant use cases. Using a Cascaded Multi-Modal Mixing Transformer (CMT), we assessed TelDems validity and (using a Cross Modal Fusion Norm - CMFN) model explainability in (i) differential diagnosis between healthy individuals, AD, and three sub-types of frontotemporal lobar degeneration (ii) disease staging from healthy cognition to mild cognitive impairment (MCI) and AD, and (iii) predicting progression from MCI to AD. Our findings show that the CMT enhances diagnostic and prognostic accuracy when incorporating multimodal data compared to unimodal modeling and that cerebrospinal fluid (CSF) biomarkers play a key role in accurate model decision making. These results reinforce the power of DL technology in tapping deeper into already existing data, thereby accelerating preclinical dementia research by utilizing clinically relevant information to disentangle complex dementia pathophysiology.
Neurology
What problem does this paper attempt to address?